Edwards Lifesciences Corporation (EW) Earnings History
Steady Earner27 years of earnings data (1999–2025) · Positive but moderate multi-year EPS trajectory
Loading earnings history...
Edwards Lifesciences Corporation (EW) Earnings Overview
As of June 22, 2026, Edwards Lifesciences Corporation (EW) reported trailing twelve-month net income of $1.07B, reflecting -73.7% year-over-year growth. The company earned $1.84 per diluted share over the past four quarters, with a net profit margin of 17.7%.
Looking at the long-term picture, EW's 5-year EPS compound annual growth rate (CAGR) stands at +7.1%, showing solid earnings momentum. The company achieved its highest annual net income of $4.17B in fiscal 2024.
Edwards Lifesciences Corporation maintains industry-leading profitability with a gross margin of 78.1%, operating margin of 27.0%, and net margin of 17.7%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including MDT ($4.61B net income, 13.9% margin), ABT ($13.98B net income, 31.9% margin), BSX ($2.89B net income, 14.4% margin), EW has outperformed on profitability metrics. Compare EW vs MDT →
EW Earnings vs Peers
Earnings metrics vs comparable public companies
EW Historical Earnings Data (1999–2025)
27 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.07B | -74.3% | $1.64B | $1.83 | 17.7% | 27.0% |
| 2024 | $4.17B | +197.7% | $1.38B | $6.97 | 76.7% | 25.3% |
| 2023 | $1.40B | -7.9% | $1.43B | $2.30 | 28.0% | 28.5% |
| 2022 | $1.52B | +1.3% | $1.70B | $2.44 | 28.3% | 31.6% |
| 2021 | $1.50B | +82.5% | $1.61B | $2.38 | 28.7% | 30.8% |
| 2020 | $823M | -21.3% | $1.30B | $1.30 | 18.8% | 29.5% |
| 2019 | $1.05B | +45.0% | $1.20B | $1.64 | 24.1% | 27.6% |
| 2018 | $722M | +16.1% | $1.09B | $1.13 | 19.4% | 29.3% |
| 2017 | $622M | +9.2% | $1.01B | $0.96 | 18.1% | 29.4% |
| 2016 | $570M | +15.1% | $816M | $0.87 | 19.2% | 27.5% |
| 2015 | $495M | -39.0% | $576M | $0.75 | 19.8% | 23.1% |
| 2014 | $811M | +107.1% | $487M | $1.25 | 34.9% | 21.0% |
| 2013 | $392M | +33.6% | $433M | $0.57 | 19.1% | 21.2% |
| 2012 | $293M | +23.9% | $397M | $0.41 | 15.4% | 20.9% |
| 2011 | $237M | +8.6% | $329M | $0.33 | 14.1% | 19.6% |
| 2010 | $218M | -4.8% | $283M | $0.31 | 15.1% | 19.5% |
| 2009 | $229M | +77.7% | $233M | $0.33 | 17.3% | 17.6% |
| 2008 | $129M | +14.1% | $209M | $0.18 | 10.4% | 16.9% |
| 2007 | $113M | -13.4% | $170M | $0.16 | 10.4% | 15.5% |
| 2006 | $131M | +64.6% | $164M | $0.18 | 12.6% | 15.8% |
| 2005 | $79M | +4564.7% | $176M | $0.11 | 7.9% | 17.6% |
| 2004 | $2M | -97.8% | $154M | $0.00 | 0.2% | 16.6% |
| 2003 | $79M | +41.8% | $138M | $0.11 | 9.2% | 16.1% |
| 2002 | $56M | +564.2% | $52M | $0.08 | 7.9% | 7.4% |
| 2001 | -$12M | +95.6% | $24M | $-0.02 | -1.7% | 3.5% |
| 2000 | -$272M | -431.7% | $95M | $-0.39 | -33.8% | 11.8% |
| 1999 | $82M | - | $117M | $0.12 | 9.1% | 12.9% |
Download Data
Export EW earnings history in CSV or JSON format
Free sign-in required to download data
Full Stock Analysis
Deep dive into EW consensus models and risk factors.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
27+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
EW — Frequently Asked Questions
Quick answers to the most common questions about buying EW stock.
What is EW earnings per share (EPS)?
EW trailing twelve-month (TTM) diluted EPS is $1.84, reflecting -73.7% year-over-year growth. The 5-year EPS CAGR is +7.1%. Complete EPS history from 1999 to 2025 is available in the table on this page.
What is Edwards Lifesciences Corporation's net income?
Edwards Lifesciences Corporation (EW) trailing twelve-month net income is $1.1B as of 2025. Earnings declined -73.7% year-over-year. Edwards Lifesciences Corporation has been profitable for 24 consecutive years.
Is EW profitable?
Yes, EW is profitable with a TTM net income of $1.1B and a net profit margin of +17.7%. Edwards Lifesciences Corporation has generated profits for 24 consecutive years.
What is EW's earnings growth rate?
EW compound annual EPS growth rates (CAGR): 1-Year: -73.7%, 3-Year: -9.1%, 5-Year: +7.1%, 10-Year: +9.3%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1999 to 2025.
What are EW's profit margins?
Edwards Lifesciences Corporation net profit margin is +17.7%, operating margin is +27.0%, and gross margin is +78.1%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +10.5%.
Is EW growing earnings?
EW earnings are declining — EPS fell -73.7% year-over-year. TTM net income dropped to $1.1B. This contrasts with the 5-year CAGR of +7.1%.
What was EW's best earnings year?
Edwards Lifesciences Corporation's highest annual net income on record is $4.2B, achieved in fiscal year 2024. Earnings history on this page spans 1999 to 2025 and includes all annual and quarterly figures.
What were EW's earnings last quarter?
EW's most recent reported quarter was Q4 2025. Net income was $91M with diluted EPS of $0.16. For a full breakdown of all quarters, see the quarterly earnings table on this page.